Company Filing History:
Years Active: 2016-2024
Title: The Innovations of Roberto Elosua Llanos
Introduction
Roberto Elosua Llanos is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of cardiovascular health through his innovative methods and technologies. With a total of 5 patents, his work focuses on improving risk assessment for cardiovascular diseases.
Latest Patents
One of his latest patents is centered on risk assessment for cardiovascular disease. This invention relates to a method for reclassifying a subject to a more appropriate risk assessment than that obtained using traditional algorithms such as Framingham, Regicor, Score, Procam, or Qrisk. The method incorporates the presence of various polymorphisms to enhance risk estimation. Additionally, it includes a method for determining the risk of suffering from cardiovascular disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for CVD. This also involves computer-implemented methods for executing the risk determination.
Another significant patent by Elosua Llanos addresses cardiovascular disease through a similar approach. It focuses on reclassifying subjects based on the presence of different polymorphisms and conventional risk factors. This innovative method aims to provide a more accurate assessment of cardiovascular risk.
Career Highlights
Throughout his career, Roberto Elosua Llanos has worked with notable companies such as Gendiag S.L. and Genincode Plc. His experience in these organizations has contributed to his expertise in the field of cardiovascular health and risk assessment.
Collaborations
He has collaborated with esteemed colleagues, including Jaume Marrugat De La Iglesia and Sergio Castillo Fernandez. These partnerships have further enriched his research and development efforts in cardiovascular innovations.
Conclusion
Roberto Elosua Llanos stands out as a key figure in the realm of cardiovascular health innovation. His patents and collaborative efforts reflect his commitment to advancing risk assessment methodologies. His work continues to have a significant impact on the field, enhancing the understanding and management of cardiovascular diseases.